Milrinone vs. Dobutamine in Cardiogenic Shock: Which is Better?
Listen now
Description
Should we use milrinone or dobutamine in patients in cardiogenic shock? NEJM published data providing us with the answer.
Show Notes: https://eddyjoemd.com/milrinone-dobutamine/
TrueLearn Link: https://truelearn.referralrock.com/l/EDDYJOEMD25/
Discount code: EDDYJOEMD25
Citation: Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le May MR, Russo JJ, Hibbert B. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. N Engl J Med. 2021 Aug 5;385(6):516-525. doi: 10.1056/NEJMoa2026845. PMID: 34347952.
---
Support this podcast: https://anchor.fm/eddyjoemd/support
More Episodes
Does Left Atrial Appendage Closure Worsen Postoperative Atrial Fibrillation Risk in Cardiac Surgery?
In this episode, we discuss recent findings on the potential risks of left atrial appendage closure (LAAC) in cardiac surgery patients without prior atrial fibrillation. The study highlights an increased risk of new-onset postoperative AF and prolonged hospital stays without clear benefits in...
Published 11/03/24
In this episode of the Saving Lives Podcast, Eddy Joe explores the TRISCEND II trial’s groundbreaking findings on transcatheter tricuspid valve replacement (TTVR) for severe tricuspid regurgitation. Learn about the quality-of-life improvements, procedural risks, and future directions for this...
Published 10/31/24
Published 10/31/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
